首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia.
【24h】

Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia.

机译:参与造血作用的microRNA的失控和HTLV-1成人T细胞白血病的免疫反应。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Human T-cell leukemia virus type-I (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL), an aggressive lymphoproliferative disease. MicroRNAs (miRNAs) are differentially expressed during hematopoiesis and lineage commitment of hematopoietic stem cell progenitors (HSCPs). Here, we report aberrant expression of hematopoietic-specific miR-223, miR-181a, miR-150, miR-142.3p, and miR-155 in HTLV-I-infected cells in vitro and uncultured ex vivo ATL cells. Our results suggest that HTLV-I-infected cells have an unbalanced expression of miRNA that favors T-cell differentiation. We also found altered expression of miRNA previously recognized as innate immunity regulators: miR-155, miR-125a, miR-132, and miR-146. Strikingly, our data also revealed significant differences between ex vivo ATL tumor cells and in vitro HTLV-I cell lines. Specifically, miR-150 and miR-223 were up-regulated in ATL patients but consistently down-regulated in HTLV-I cell lines, suggesting that ATL cells and in vitro-established cells are derived from distinct cellular populations.
机译:I型人T细胞白血病病毒(HTLV-1)是成人T细胞白血病(ATL)的病原体,ATL是一种侵略性淋巴增生性疾病。 MicroRNA(miRNA)在造血干细胞和造血干细胞祖细胞(HSCP)的血统承诺期间差异表达。在这里,我们报告在体外和未培养的离体ATL细胞中,造血特异性miR-223,miR-181a,miR-150,miR-142.3p和miR-155在HTLV-1感染的细胞中异常表达。我们的研究结果表明,感染HTLV-I的细胞具有不平衡的miRNA表达,有利于T细胞分化。我们还发现以前被公认是先天性免疫调节剂的miRNA的表达发生了变化:miR-155,miR-125a,miR-132和miR-146。令人惊讶的是,我们的数据还揭示了离体ATL肿瘤细胞与体外HTLV-1细胞系之间的显着差异。具体而言,在ATL患者中miR-150和miR-223被上调,但在HTLV-1细胞系中始终被下调,这表明ATL细胞和体外建立的细胞均来自不同的细胞群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号